SPY002-072
SPY002-072-201
Phase 2 small_molecule active
Quick answer
SPY002-072 for Rheumatoid Arthritis is a Phase 2 program (small_molecule) at Spyre Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Spyre Therapeutics
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active